SCHEMBL21189186

SCHEMBL21189186

CC(C)(C)OC(=O)N[C@H]1CCOc2c(C(=O)Nc3ccc(F)c(Cl)c3)ccc(F)c21

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.44
CNR1 P21554 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
GPR35 Q9HC97 1/20 0.44
GPR55 Q9Y2T6 1/20 0.44
SMN1; SMN2 Q16637 5/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 1/20 0.41
NPC1 O15118 6/20 0.41
RAB9A P51151 6/20 0.41
FADS1 O60427 1/20 0.40
HTT P42858 3/20 0.40
RORC P51449 1/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.38
CPT2 P23786 1/20 0.38
CPT1A P50416 1/20 0.38
CPT1B Q92523 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21189195 0.91 NPC1 (0.46) MAPTNPSR1SMN1; SMN2MEN1KMT2A
SCHEMBL21189275 0.91 NPC1 (0.46) MAPTNPSR1SMN1; SMN2MEN1KMT2A
SCHEMBL21189276 0.91 NPC1 (0.46) MAPTNPSR1SMN1; SMN2MEN1KMT2A
SCHEMBL19973410 0.86 KMT2A (0.46) MAPTNPSR1SMN1; SMN2MEN1KMT2A
SCHEMBL19973456 0.86 KMT2A (0.46) MAPTNPSR1SMN1; SMN2MEN1KMT2A
SCHEMBL19973411 0.86 KMT2A (0.46) MAPTNPSR1SMN1; SMN2MEN1KMT2A
SCHEMBL21189308 0.86 MAPT (0.49) MAPTCNR1NPSR1GPR35GPR55
SCHEMBL19973490 0.85 KMT2A (0.47) MAPTNPSR1SMN1; SMN2MEN1KMT2A
SCHEMBL19973489 0.85 KMT2A (0.47) MAPTNPSR1SMN1; SMN2MEN1KMT2A
Hydrochloric Acid SCHEMBL19973481 0.85 KMT2A (0.46) MAPTNPSR1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS MAPT 3165/4885CNR1 146/4885NPSR1 4645/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS MAPT 3165/4885CNR1 146/4885NPSR1 4645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.